NNRT-IN-13
NNRT-IN-13 is a potent non-nucleoside reverse transcriptase (NNRT) inhibitor that directly inhibiting HIV-1 reverse transcriptase (IC₅₀ = 0.25 μM). NNRT-IN-13 exhibits excellent antiviral activity against wild-type HIV-1 (EC₅₀ = 0.0046 μM) and a broad spectrum of drug-resistant mutants. NNRT-IN-13 exhibits favorable in vivo metabolic and safety profiles. NNRT-IN-13 can be used for human immunodeficiency virus (HIV) research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C31H34N8O4S
- 分子量:614.72
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
NNRT-IN-13 (compound 15k) exhibits excellent activity against wild-type HIV-1 (EC₅₀ = 0.0046 μM) and a broad spectrum of drug-resistant mutants, including L100I (0.0053 μM), K103N (0.0034 μM), Y181C (0.010 μM), Y188L (0.026 μM), E138 K (0.015 μM), F227L/V106A (0.033μM), and K103N/Y181C (0.029 μM), while displaying low cytotoxicity in MT-4 cells (CC50 = 26.64 μM)[1].
NNRT-IN-13 binds HIV-1 reverse transcriptase in a unique "Y-shaped" mode, forming novel hydrogen bonds with the p51-p66 interface residues E138 and K101[1].
NNRT-IN-13 exhibits no inhibition toward CYP1A2, CYP2C9, CYP2C19, and CYP2D6, with IC50 values exceeding 50 μM, and shows weak inhibition of CYP3A4M (IC50 = 13.6 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming mice[1]
-
Dosage:2000 mg/kg
-
Administration:i.p., single dose
-
Result:Showed no mortality or adverse toxicity signs, including anorexia, lethargy, alopecia, or dyspnea.
Exhibited steady weight gain over the seven-day observation period, with no significant differences compared to control.
-
Animal Model:Kunming mice[1]
-
Dosage:50 mg/kg
-
Administration:i.p., every other day for 14 days
-
Result:Showed no apparent toxicity signs or behavioral abnormalities (such as lethargy, clonic convulsions, anorexia, and ruffled fur.
Gained normal body weight and were equivalent to those of the control group.
Exhibited no visible pathological changes or lesions were detected in the heart, liver, spleen, lungs, or kidneys.
化学情報
-
分子量 614.72
-
分子式 C31H34N8O4S
-
SMILES
O=S(C1=CC=C(CN2CCC(NC3=NC(OC4=C(C=C(C=C4C)/C=C/C#N)C)=CC(NCC5=COC=N5)=N3)CC2)C=C1)(N)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
NNRT-IN-13 関連分類
HY-178341 関連分類
Powered by Bioz